Synexus Polska Sp. z o.o. Oddział w Katowicach
- Address
- Ul. Konckiego 3, 40-040 Katowice, Poland
Synexus Polska Sp. z o.o. Oddział w Katowicach - Dermatology and Immunology Research
Synexus Polska Sp. z o.o. Oddział w Katowicach is a dedicated clinical research facility specializing in dermatological and immunological conditions. The center focuses on advancing treatment options for patients with chronic inflammatory skin disorders through participation in international Phase 3 clinical trials.
- Chronic Spontaneous Urticaria (CSU) and autoimmune skin conditions
- Novel biologic therapies targeting mast cell pathways
- Advanced assessment of urticaria activity and quality of life measures
The facility demonstrates expertise in evaluating urticaria activity scores and implementing sophisticated patient-reported outcome measures. Their participation in the EMBARQ program reflects their commitment to studying innovative therapeutic approaches, including barzolvolimab, which targets underlying immune mechanisms in chronic spontaneous urticaria. This research contributes to expanding treatment options for patients who experience persistent hives and may not respond adequately to conventional antihistamine therapy.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 23 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Akero Therapeutics Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Synexus Polska Sp. z o.o. Oddział w Katowicach
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A parallel-group treatment, proof-of-concept Phase 2, multicenter, double-blind, randomized 2 arm clinical trial to investigate the efficacy and safety of subcutaneous NT 201 injections compared with placebo injections in decreasing pain intensity in male and female participants aged 18 years and older with moderate or severe chronic neuropathic pain due to postherpetic neuralgia or peripheral nerve injury. | Merz Therapeutics GmbH | Phase II | Not Recruiting | Oct 2023 | Jun 2025 |
IMP list
lock Showing 1 of 23 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| A/Victoria/2570/2019 (H1N1)Pdm09-Like Strain (A/Victoria/2570/2019, Ivr-215) | 1 | Unknown | 2023-11-06 | 2023-11-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.